Features of the use of sepsis biomarkers after liver transplantation
Open Access
- 11 December 2025
- journal article
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 17 (4) , 479-493
Abstract
Background . Liver transplantation is the only radical treatment for end-stage liver diseases; however, postoperative infectious complications, particularly sepsis, significantly worsen prognosis and increase mortality. Sepsis after liver transplantation develops in 20–40% of recipients and is associated with high mortality (up to 50%), which is caused by immunosuppressive therapy, surgical trauma, and the baseline severity of the patient's condition. Objective . To provide a literature review on sepsis biomarkers after liver transplantation. Material and methods . Analysis of scientific publications in PubMed, Google Scholar, and Medline databases for the period 2015–2025 on the topic of sepsis biomarkers after liver transplantation. Results . The main groups of sepsis biomarkers after liver transplantation were identified and systematized: immunological (T-cell clonality, sTREM-1, presepsin, cytokines), biochemical (procalcitonin, hyaluronic acid, bilirubin, INR), hematological (neutrophil-lymphocyte ratio, platelets), genetic and epigenetic (microRNA, long non-coding RNA). Combined prediction algorithms using clinical scales (SOFA, MELD) and machine learning methods were analyzed. Conclusion . Current data indicates significant prognostic potential of sepsis biomarkers after liver transplantation. The most promising direction is the combination of immunological (T-cell clonality, sTREM-1) and biochemical (PCT, HA) markers, integration of traditional scales (SOFA, MELD) with machine learning algorithms, and the use of genetic and epigenetic markers for a personalized approach. Implementation of these approaches in clinical practice will significantly improve outcomes in liver recipients through early diagnosis of sepsis, timely initiation of therapy, and personalized immunosuppressive treatment.Keywords
This publication has 25 references indexed in Scilit:
- Microbiome composition recovery after liver transplantation correlates with initial liver disease severity and antibiotics treatmentAmerican Journal of Transplantation, 2024
- Impact of sarcopenia on the survival of patients undergoing liver transplantation for decompensated liver cirrhosisJournal of Cachexia, Sarcopenia and Muscle, 2023
- Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021Intensive Care Medicine, 2021
- Liver Transplantation2021
- Post‐transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 TransplantsLiver Transplantation, 2021
- Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter StudyInfectious Diseases and Therapy, 2020
- COVID-19 in liver transplant recipients: preliminary data from the ELITA/ELTR registryThe Lancet Gastroenterology & Hepatology, 2020
- Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survivalJournal of Hepatology, 2020
- Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcomeJournal of Hepatology, 2013
- Clinical Hepatology2010